Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
Journal of Neuro-Oncology · 2023-08 · 164 (1) · 55-64
DOI: 10.1007/s11060-023-04357-9 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 16.08.2023. Verfasst von Lorena Gurrieri und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IR…. Hauptthemen laut MEDLINE: Glioblastoma, Neurosurgery, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aims of our retrospective study investigated the role of immune system in glioblastoma (GBM), which is the most aggressive primary brain tumor in adults characterized by a poor prognosis. The recurrence rate remains high, probably due to “immune-desert” tumor microenvironment (TME) making GBM hidden from the anti-tumoral immune clearance. Considering this, we aimed to create a panel of prognostic markers from blood and tumor tissue correlating with overall survival (OS) and progression-free survival (PFS).
Methods
Firstly, we analyzed the inflammatory markers NLR and PLR as the ratio of the absolute neutrophil count and absolute platelet count by the absolute lymphocyte count respectively, collected at different time points in the peripheral blood of 95 patients. Furthermore, in 31 patients of the same cohort, we analyzed the formalin-fixed paraffin embedded samples to further compare the impact of circulating and inflammatory markers within the TME.
Results
Patients aged < 60 years and with methylated MGMT showed better OS. While, pre-chemotherapy Systemic Inflammatory Index (SII) < 480 was related to a better OS and PFS, we observed that only CD68+macrophage and CD66b+neutrophils expressed in vascular/perivascular area (V) showed a statistically significant prognostic role in median OS and PFS.
Conclusions
Thus, we underscored a role of SII as predictive value of response to STUPP protocol. Regarding the TME-related markers, we suggested to take into consideration for future studies with new immunotherapy combinations, each component relating to expression of immune infiltrating subsets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014, Meldola, Italy.
- Preclinic and Osteoncology Unit, Bioscience Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014, Meldola, Italy.
- Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, 40138, Bologna, Italy.
- Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014, Meldola, Italy. valen…
- Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014, Meldola, Italy.
- Department of Medical Oncology, "Infermi" Hospital, 47921, Rimini, Italy.
Zitieren
APA
Gurrieri, L., Mercatali, L., Ibrahim, T., Fausti, V., Dall'Agata, M., Riva, N., Ranallo, N., Pasini, G., Tazzari, M., Foca, F., Bartolini, D., Riccioni, L., Cavatorta, C., Morigi, F. P., Bulgarelli, J., Cocchi, C., Ghini, V., Tosatto, L., Martinelli, G., …, & Ridolfi, L. (2023). Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series. Journal of Neuro-Oncology, 164(1), 55-64. https://doi.org/10.1007/s11060-023-04357-9
Vancouver
Gurrieri L, Mercatali L, Ibrahim T, Fausti V, Dall'Agata M, Riva N, et al. Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series. Journal of Neuro-Oncology. 2023;164(1):55-64. doi:10.1007/s11060-023-04357-9
BibTeX
@article{Gurrieri2023,
author = {Gurrieri, Lorena and Mercatali, Laura and Ibrahim, Toni and Fausti, Valentina and Dall'Agata, Monia and Riva, Nada and Ranallo, Nicoletta and Pasini, Giuseppe and Tazzari, Marcella and Foca, Flavia and Bartolini, Daniela and Riccioni, Luca and Cavatorta, Chiara and Morigi, Federico Paolo and Bulgarelli, Jenny and Cocchi, Claudia and Ghini, Virginia and Tosatto, Luigino and Martinelli, Giovanni and Pession, Andrea and Ridolfi, Laura},
title = {Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series},
journal = {Journal of Neuro-Oncology},
year = {2023},
volume = {164},
number = {1},
pages = {55--64},
doi = {10.1007/s11060-023-04357-9}
}
EUVIMED